Tag: targeted therapy market data

  • Targeted Therapy Market Growth Potential: Key Insights for 2024-2033

    Targeted Therapy Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Targeted Therapy Market Grow from 2024 to 2033?

    The market size for targeted therapy has significantly increased in the recent past. It is forecasted to expand from $97.72 billion in 2023 to $105.06 billion in 2024, maintaining a steady compound annual growth rate (CAGR) of 7.5%. This substantial growth in the past years can be owed to the progression made in molecular biology, rising instances of cancer, the trend towards personalized medicine, FDA’s endorsement, and regulatory support.

    In the coming years, the market size for targeted therapy is predicted to exhibit robust growth, escalating to $140.77 billion in 2028 with a 7.6% compound annual growth rate (CAGR). The increased growth projected for this period can be credited to the progression in oncology research, the surge in demand for precision medicine, the advent of immunotherapies, increased funding in biopharmaceuticals, and heightened patient awareness and advocacy. During this forecast period, significant trends will consist of the incorporation of artificial intelligence (AI) in drug discovery, patient advocacy and participation in treatment choices, the extension of companion diagnostics, regulatory encouragement for accelerated approvals, and heightened investment in biotechnology and pharma.

    Claim Your Free Sample of the Global Targeted Therapy Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    What Aspects Are Influencing the Growth Rate of the targeted therapy Market?

    The escalating incidence of cancer is forecasted to stimulate the growth of the targeted therapy market. Cancer, described as a condition where errant cells proliferate without control and invade neighboring tissues, is on the rise. Targeted therapy interrupts the signals that incite the growth of cancer cells or commands the cancer cells to eliminate themselves. This therapy utilizes medication to specifically target the genes and proteins that foster the growth and survival of cancer cells, which consequently heightens its demand. For example, in September 2021, according to the National Cancer Institute, a US government organization that is a part of the National Institutes of Health, it was reported that 1,806,590 new cancer cases were logged, pointing to a 43% increase from the previous year. Hence, the rising prevalence of cancer is propelling the growth of the targeted therapy market.

    What Are the Critical Segments of the Targeted Therapy Market?

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    What Trends Are Redefining Consumer Expectations in the Targeted Therapy Market?

    Order Now for Fast Delivery of Your Targeted Therapy Market Report!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    What Are the Leading Regions in the Targeted Therapy Market Expansion?

    North America was the largest region in the targeted therapy market in 2023. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Targeted Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the targeted therapy market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Targeted Therapy Market Include

    1. Targeted Therapy Market Executive Summary

    2. Targeted Therapy Market Segments

    3. Targeted Therapy Market Size And Template Market Growth Rate

    4. Key Targeted Therapy Market Trends

    5. Major Targeted Therapy Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Targeted Therapy Market

    26. Top Targeted Therapy Companies

    27. Targeted Therapy Market Opportunities And Strategies

    28. Targeted Therapy Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    Cell and Gene Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Targeted Therapy Market 2024

    5 Key Insights On The Targeted Therapy Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Targeted Therapy Global Market Report 2024, the targeted therapy market is expected to show significant growth in the forecast period.

    Strong Recent Growth in Targeted Therapy Market

    The targeted therapy market has experienced significant growth in recent years.

    • Market Size Growth: The market size increased from $97.72 billion in 2023 to $105.06 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.5%.
    • Contributing Factors: Advancements in molecular biology, rising cancer incidence, personalized medicine trends, FDA approvals, and regulatory support have driven this growth.

    Projected Growth and Key Drivers

    Looking ahead, the targeted therapy market is set to continue its robust growth.

    • Future Market Size: Expected to reach $140.77 billion by 2028, with a CAGR of 7.6%.
    • Growth Drivers: Expanding oncology research, rising demand for precision medicine, emergence of immunotherapies, increasing investment in biopharmaceuticals, and heightened patient awareness and advocacy.

    Major Trends Shaping the Future

    Several key trends are anticipated to shape the targeted therapy market in the coming years.

    • AI Integration: Incorporation of artificial intelligence in drug discovery.
    • Patient Advocacy: Increased patient involvement in treatment decisions.
    • Companion Diagnostics: Expansion in the use of companion diagnostics.
    • Regulatory Support: Enhanced regulatory support for expedited approvals.
    • Investment in Biotechnology: Rising investment in biotechnology and pharmaceuticals.

    View More On The Targeted Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Rising Cancer Prevalence Fuels Surge in Demand

    The growing prevalence of cancer is a significant factor propelling the targeted therapy market.

    • Cancer Statistics: According to the National Cancer Institute, there were 1,806,590 new cancer cases registered in September 2021, a 43% increase from the previous year.
    • Therapy Benefits: Targeted therapy disables signals that promote cancer cell growth or triggers cancer cell self-destruction, increasing its demand.

    Leading Companies in the Market

    Major players in the targeted therapy market include:

    • Pfizer Inc.
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co Inc.
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG
    • Sanofi SA
    • Gilead Sciences Inc.
    • Seagen Inc.
    • Exelixis Inc.
    • Seattle Genetics Inc.
    • Genentech Inc.
    • Daiichi Sankyo Company Limited
    • ChemGenex Pharmaceuticals Ltd

    Advanced Targeted Therapy Market with FDA Approval

    Companies in the targeted therapy market are focusing on developing advanced technological solutions to strengthen their market position.

    • Novartis AG: In March 2022, Novartis launched Pluvicto, the first FDA-approved targeted radioligand therapy for eligible patients with mCRPC. This therapy combines a therapeutic radioisotope with a targeting chemical to attack cancer cells effectively.

    Strategic Acquisitions Strengthen Precision Oncology Portfolios

    Strategic acquisitions are also playing a crucial role in expanding the capabilities and offerings of leading companies in the market.

    • Bristol Myers Squibb: Acquired Turning Point Therapeutics in August 2022. This acquisition enhances Bristol Myers Squibb’s ability to address non-small cell lung cancer with ROS1-positive mutations and provides access to a pipeline of experimental drugs targeting oncogenesis-related mutations.

    Market Segmentation

    The targeted therapy market is segmented into:

    • By Type: Small Molecule Medicines, Monoclonal Antibodies
    • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
    • By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Regional Insights

    • North America: The largest region in the targeted therapy market in 2023, driven by advanced healthcare infrastructure, significant investment in research, and high adoption of new technologies.

    The targeted therapy market is on a trajectory of continued expansion, driven by technological advancements, strategic acquisitions, and a growing focus on personalized medicine. With ongoing research and development, the market is poised for significant innovations and improvements in cancer treatment.

    Request A Sample Of The Global Targeted Therapy Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9129&type=smp